Member Exclusive

Accelerating the development of protein degradation therapeutics

Kymera Therapeutics (MA, USA) announces partnership with GlaxoSmithKline (London, UK) for the development of protein degrading therapeutics.

Go to the profile of Jasmine Harris
Apr 05, 2018

Please sign in or register for FREE

Register to MedChemNet

MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet.